YAP1 and obesity due to melanocortin 4 receptor deficiency: Together, these findings indicated that the YAP‐mediated antioxidative capacity plays a crucial role in breast cancer development and it confers clinical impacts of the YAP‐antioxidant axis in obesity‐associated breast cancer.